03.07.2012
- When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative...
19.06.2012
- Fujifilm Diosynth Biotechnologies has announced it is further increasing its contract process development and manufacturing capabilities through the expansion of its services in...
14.06.2012
- Modern Excipients - Traditionally, excipients have never received the same attention as that given to the Active Pharmaceutical ingredient (API). Instead they have been seen as...
06.06.2012
- Germany's Merck KGaA and India's Dr. Reddy's Laboratories have struck a deal to develop cheap versions of biotech cancer drugs, seeking to tap into a new market as patents on...
31.05.2012
- Industrial Biotech - The growing shortage and rising price of fossil energy has increased interest in finding economically attractive replacements that draw on biotechnology...
30.05.2012
- Billionaire investor Carl Icahn, who last year failed to get his nominees elected to the board of Forest Laboratories, plans to back another slate of directors at the drugmaker's...
28.05.2012
- Biotechnology company Amylin Pharmaceuticals has drawn initial bids from drugmakers Merck & Co and Sanofi, Bloomberg News reported on Friday, citing anonymous sources. The...
25.05.2012
- Knock-out data for Actelion's big new drug hope could be a double-edged sword for embattled founder and CEO Jean-Paul Clozel, making it a worthy buy for pharma companies hungry for...
